Rein Therapeutics Inc (RNTX) Income Statement

Total revenue

--0.00

Revenue

--0.00

Operating expenses

-22.15%5.61M

-20.61%5.80M

207.08%6.07M

334.57%9.04M

80.62%7.21M

55.26%7.30M

-69.50%1.98M

-74.13%2.08M

-52.63%3.99M

-31.00%4.70M

-4.55%6.48M

33.82%8.04M

20.49%8.42M

62.60%6.82M

35.06%6.79M

36.57%6.01M

1.64%6.99M

-42.96%4.19M

-36.48%5.03M

-40.37%4.40M

-5.98%6.88M

5.26%7.35M

5.56%7.92M

-23.60%7.38M

-5.80%7.31M

-0.84%6.98M

16.68%7.50M

95.05%9.66M

69.17%7.76M

58.30%7.04M

51.84%6.43M

-10.77%4.95M

16.50%4.59M

34.46%4.45M

32.13%4.23M

--5.55M

--3.94M

--3.31M

--3.20M

R&D expenses

-11.81%3.05M

68.46%3.32M

9959.46%3.72M

1900.53%3.74M

91.33%3.46M

-17.90%1.97M

-99.13%37.00K

-96.56%187.00K

-69.29%1.81M

-47.34%2.40M

-0.91%4.24M

41.01%5.43M

36.54%5.89M

136.94%4.56M

59.39%4.28M

54.86%3.85M

6.07%4.32M

-59.13%1.93M

-40.02%2.68M

-42.19%2.49M

-2.52%4.07M

18.91%4.71M

3.56%4.47M

-19.10%4.30M

-13.87%4.17M

-8.12%3.96M

12.97%4.32M

68.30%5.32M

64.72%4.85M

39.42%4.31M

46.83%3.83M

51.53%3.16M

18.01%2.94M

52.99%3.09M

46.68%2.60M

--2.09M

--2.49M

--2.02M

--1.78M

Depreciation, depletion, and amortization

-100.00%0.00

-66.67%4.00K

37.21%59.00K

20.93%52.00K

-72.09%12.00K

-71.43%12.00K

4.88%43.00K

7.50%43.00K

10.26%43.00K

5.00%42.00K

1950.00%41.00K

300.00%40.00K

178.57%39.00K

-42.03%40.00K

-97.14%2.00K

-86.67%10.00K

-36.36%14.00K

155.56%69.00K

125.81%70.00K

53.06%75.00K

-74.71%22.00K

-25.00%27.00K

-32.61%31.00K

11.36%49.00K

117.50%87.00K

56.52%36.00K

109.09%46.00K

4.76%44.00K

-31.03%40.00K

-64.62%23.00K

-67.16%22.00K

-40.00%42.00K

-31.76%58.00K

--65.00K

--67.00K

--70.00K

--85.00K

Other operating expenses

----

---15.00K

----

Operating profit

22.15%-5.61M

20.61%-5.80M

-207.08%-6.07M

-334.57%-9.04M

-80.62%-7.21M

-55.26%-7.30M

69.50%-1.98M

74.13%-2.08M

52.63%-3.99M

31.00%-4.70M

4.55%-6.48M

-33.82%-8.04M

-20.49%-8.42M

-62.60%-6.82M

-35.06%-6.79M

-36.57%-6.01M

-1.64%-6.99M

42.96%-4.19M

36.48%-5.03M

40.37%-4.40M

5.98%-6.88M

-5.26%-7.35M

-5.56%-7.92M

23.60%-7.38M

5.80%-7.31M

0.84%-6.98M

-16.68%-7.50M

-95.05%-9.66M

-69.17%-7.76M

-58.30%-7.04M

-51.84%-6.43M

10.77%-4.95M

-16.50%-4.59M

-34.46%-4.45M

-32.13%-4.23M

---5.55M

---3.94M

---3.31M

---3.20M

Net non-operating interest income (expenses)

Non-operating interest income

----

-35.00%78.00K

40.91%155.00K

128.57%112.00K

161.90%55.00K

--120.00K

423.81%110.00K

157.89%49.00K

50.00%21.00K

----

320.00%21.00K

90.00%19.00K

-77.42%14.00K

----

-96.99%5.00K

-95.17%10.00K

-38.00%62.00K

--114.00K

--166.00K

23.21%207.00K

-42.86%100.00K

----

479.31%168.00K

446.88%175.00K

2833.33%176.00K

1570.00%167.00K

81.25%29.00K

128.57%32.00K

500.00%6.00K

400.00%10.00K

--16.00K

--14.00K

--1.00K

--2.00K

Special income (expenses)

----

-308433.33%-37.00M

100.00%0.00

-100.00%0.00

100.00%0.00

--12.00K

---6.00K

--88.00K

---1.02M

----

- Gains from disposal of fixed assets

----

113.05%100.00K

----

-100.00%0.00

---766.00K

--0.00

----

--66.00K

----

Other non-operating income (expenses)

17.39%108.00K

314.17%272.00K

22300.00%224.00K

4.30%97.00K

-48.02%92.00K

-452.78%-127.00K

-75.00%1.00K

--93.00K

904.55%177.00K

224.14%36.00K

-93.94%4.00K

-100.00%0.00

---22.00K

23.68%-29.00K

--66.00K

--304.00K

----

---38.00K

----

Income before tax

22.66%-5.50M

-479.44%-42.52M

-220.03%-5.85M

-400.39%-8.94M

-48.84%-7.11M

-61.40%-7.34M

71.31%-1.83M

77.64%-1.79M

43.26%-4.78M

33.12%-4.55M

5.01%-6.37M

-40.56%-7.99M

-20.75%-8.42M

-36.09%-6.80M

-33.47%-6.70M

-29.52%-5.69M

-3.36%-6.97M

30.95%-5.00M

35.18%-5.02M

38.79%-4.39M

6.45%-6.75M

-2.86%-7.24M

-4.24%-7.75M

24.43%-7.17M

4.94%-7.21M

-2.46%-7.03M

-18.77%-7.43M

-92.79%-9.49M

-66.51%-7.59M

-54.55%-6.87M

-48.25%-6.26M

11.04%-4.92M

-16.10%-4.56M

-34.32%-4.44M

-31.90%-4.22M

---5.53M

---3.92M

---3.31M

---3.20M

Income tax

----

---1.54M

----

--0.00

----

--0.00

----

--0.00

Income after tax

22.66%-5.50M

-458.40%-40.98M

-220.03%-5.85M

-400.39%-8.94M

-48.84%-7.11M

-61.40%-7.34M

71.31%-1.83M

77.64%-1.79M

43.26%-4.78M

33.12%-4.55M

5.01%-6.37M

-40.56%-7.99M

-20.75%-8.42M

-36.09%-6.80M

-33.47%-6.70M

-29.52%-5.69M

-3.36%-6.97M

30.95%-5.00M

35.18%-5.02M

38.79%-4.39M

6.45%-6.75M

-2.86%-7.24M

-4.24%-7.75M

24.43%-7.17M

4.94%-7.21M

-2.46%-7.03M

-18.77%-7.43M

-92.79%-9.49M

-66.51%-7.59M

-54.55%-6.87M

-48.25%-6.26M

11.04%-4.92M

-16.10%-4.56M

-34.32%-4.44M

-31.90%-4.22M

---5.53M

---3.92M

---3.31M

---3.20M

Net income from continuous operations

22.66%-5.50M

-458.40%-40.98M

-220.03%-5.85M

-400.39%-8.94M

-48.84%-7.11M

-61.40%-7.34M

71.31%-1.83M

77.64%-1.79M

43.26%-4.78M

33.12%-4.55M

5.01%-6.37M

-40.56%-7.99M

-20.75%-8.42M

-36.09%-6.80M

-33.47%-6.70M

-29.52%-5.69M

-3.36%-6.97M

30.95%-5.00M

35.18%-5.02M

38.79%-4.39M

6.45%-6.75M

-2.86%-7.24M

-4.24%-7.75M

24.43%-7.17M

4.94%-7.21M

-2.46%-7.03M

-18.77%-7.43M

-92.79%-9.49M

-66.51%-7.59M

-54.55%-6.87M

-48.25%-6.26M

11.04%-4.92M

-16.10%-4.56M

-34.32%-4.44M

-31.90%-4.22M

---5.53M

---3.92M

---3.31M

---3.20M

Non-recurring net income

----

--0.00

----

Net income attributable to controlling interests

22.66%-5.50M

-458.40%-40.98M

-220.03%-5.85M

-400.39%-8.94M

-48.84%-7.11M

-61.40%-7.34M

71.31%-1.83M

77.64%-1.79M

43.26%-4.78M

33.12%-4.55M

5.01%-6.37M

-40.56%-7.99M

-20.75%-8.42M

-36.09%-6.80M

-33.47%-6.70M

-29.52%-5.69M

-3.36%-6.97M

30.95%-5.00M

35.18%-5.02M

38.79%-4.39M

6.45%-6.75M

-2.86%-7.24M

-4.24%-7.75M

24.43%-7.17M

4.94%-7.21M

-2.46%-7.03M

-18.77%-7.43M

-91.97%-9.49M

-65.79%-7.59M

-53.92%-6.87M

-47.58%-6.26M

10.97%-4.94M

-16.08%-4.58M

-34.14%-4.46M

-31.75%-4.24M

---5.55M

---3.94M

---3.33M

---3.22M

Preferred share dividend

----

--0.00

-100.00%0.00

10.53%21.00K

11.11%20.00K

0.00%18.00K

5.56%19.00K

--19.00K

--18.00K

Net income attributable to common shareholders

22.66%-5.50M

-458.40%-40.98M

-220.03%-5.85M

-400.39%-8.94M

-48.84%-7.11M

-61.40%-7.34M

71.31%-1.83M

77.64%-1.79M

43.26%-4.78M

33.12%-4.55M

5.01%-6.37M

-40.56%-7.99M

-20.75%-8.42M

-36.09%-6.80M

-33.47%-6.70M

-29.52%-5.69M

-3.36%-6.97M

30.95%-5.00M

35.18%-5.02M

38.79%-4.39M

6.45%-6.75M

-2.86%-7.24M

-4.24%-7.75M

24.43%-7.17M

4.94%-7.21M

-2.46%-7.03M

-18.77%-7.43M

-91.97%-9.49M

-65.79%-7.59M

-53.92%-6.87M

-47.58%-6.26M

10.97%-4.94M

-16.08%-4.58M

-34.14%-4.46M

-31.75%-4.24M

---5.55M

---3.94M

---3.33M

---3.22M

Basic earnings per share

70.70%-0.25

-22.82%-1.89

32.91%-0.27

-14.12%-0.45

18.58%-0.86

-53.62%-1.54

71.31%-0.40

77.64%-0.39

43.35%-1.05

33.29%-1.00

5.31%-1.40

-39.98%-1.76

-11.03%-1.86

38.35%-1.50

42.04%-1.48

55.29%-1.26

65.53%-1.67

53.15%-2.43

54.16%-2.55

46.03%-2.81

50.16%-4.85

45.53%-5.20

44.76%-5.57

59.54%-5.21

5.48%-9.74

-2.31%-9.54

-18.62%-10.09

-91.68%-12.88

-65.54%-10.30

-53.78%-9.32

-47.50%-8.50

10.99%-6.72

-16.08%-6.22

-34.14%-6.06

-31.75%-5.77

---7.55

---5.36

---4.52

---4.38

Diluted earnings per share

70.70%-0.25

-22.82%-1.89

32.91%-0.27

-14.12%-0.45

18.58%-0.86

-53.62%-1.54

71.31%-0.40

77.64%-0.39

43.35%-1.05

33.29%-1.00

5.31%-1.40

-39.98%-1.76

-11.03%-1.86

38.35%-1.50

42.04%-1.48

55.29%-1.26

65.53%-1.67

53.15%-2.43

54.16%-2.55

46.03%-2.81

50.16%-4.85

45.53%-5.20

44.76%-5.57

59.54%-5.21

5.48%-9.74

-2.31%-9.54

-18.62%-10.09

-91.68%-12.88

-65.54%-10.30

-53.78%-9.32

-47.50%-8.50

10.99%-6.72

-16.08%-6.22

-34.14%-6.06

-31.75%-5.77

---7.55

---5.36

---4.52

---4.38

Dividend per share

--0.00

Currency unit

USD

Audit opinions

--

Rein Therapeutics Inc

1.120USD

Rein Therapeutics Inc

1.120

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement